These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32591937)

  • 21. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
    Wilens TE; Adler LA; Adams J; Sgambati S; Rotrosen J; Sawtelle R; Utzinger L; Fusillo S
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):21-31. PubMed ID: 18174822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collegiate misuse of prescription stimulants: examining differences in self-worth.
    Giordano AL; Prosek EA; Reader EA; Bevly CM; Turner KD; LeBlanc YN; Vera RA; Molina CE; Garber SA
    Subst Use Misuse; 2015 Feb; 50(3):358-65. PubMed ID: 25474729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
    Lawson KA; Johnsrud M; Hodgkins P; Sasané R; Crismon ML
    Clin Ther; 2012 Apr; 34(4):944-956.e4. PubMed ID: 22444786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.
    Lachaine J; Beauchemin C; Sasane R; Hodgkins PS
    Postgrad Med; 2012 May; 124(3):139-48. PubMed ID: 22691908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
    Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
    Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
    Moran LV; Ongur D; Hsu J; Castro VM; Perlis RH; Schneeweiss S
    N Engl J Med; 2019 Mar; 380(12):1128-1138. PubMed ID: 30893533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?
    Calver J; Sanfilippo F; Preen D; Bulsara M
    Aust N Z J Public Health; 2007 Dec; 31(6):533-9. PubMed ID: 18081573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan.
    Wang LJ; Yang KC; Lee SY; Yang CJ; Huang TS; Lee TL; Yuan SS; Shyu YC
    PLoS One; 2016; 11(8):e0161061. PubMed ID: 27518196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physician practices to prevent ADHD stimulant diversion and misuse.
    Colaneri N; Keim S; Adesman A
    J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of long-term ADHD medication use in Australian children.
    Efron D; Mulraney M; Sciberras E; Hiscock H; Hearps S; Coghill D
    Arch Dis Child; 2020 Jun; 105(6):593-597. PubMed ID: 31937570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of stimulant medication on divergent and convergent thinking tasks related to creativity in adults with attention-deficit hyperactivity disorder.
    McBride M; Appling C; Ferguson B; Gonzalez A; Schaeffer A; Zand A; Wang D; Sam A; Hart E; Tosh A; Fontcha I; Parmacek S; Beversdorf D
    Psychopharmacology (Berl); 2021 Dec; 238(12):3533-3541. PubMed ID: 34477886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder.
    Perwien A; Hall J; Swensen A; Swindle R
    J Manag Care Pharm; 2004; 10(2):122-9. PubMed ID: 15032561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The female side of pharmacotherapy for ADHD-A systematic literature review.
    Kok FM; Groen Y; Fuermaier ABM; Tucha O
    PLoS One; 2020; 15(9):e0239257. PubMed ID: 32946507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder.
    Emilsson M; Gustafsson PA; Öhnström G; Marteinsdottir I
    Eur Child Adolesc Psychiatry; 2017 May; 26(5):559-571. PubMed ID: 27848023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention-Deficit/Hyperactivity Disorder in 2- to 5-Year-Olds: A Primary Care Network Experience.
    Bannett Y; Feldman HM; Gardner RM; Blaha O; Huffman LC
    Acad Pediatr; 2021 Mar; 21(2):280-287. PubMed ID: 32360494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder.
    Olfson M; Marcus SC; Zhang HF; Wan GJ
    J Manag Care Pharm; 2007 Sep; 13(7):570-7. PubMed ID: 17874863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.